11 results on '"Wu, Joyce Y."'
Search Results
2. Common epilepsy variants from the general population are not associated with epilepsy among individuals with tuberous sclerosis complex.
- Author
-
Richard, Melissa A., Lupo, Philip J., Ehli, Erik A., Sahin, Mustafa, Krueger, Darcy A., Wu, Joyce Y., Bebin, Elizabeth M., Au, Kit Sing, Northrup, Hope, and Farach, Laura S.
- Abstract
Common genetic variants identified in the general population have been found to increase phenotypic risks among individuals with certain genetic conditions. Up to 90% of individuals with tuberous sclerosis complex (TSC) are affected by some type of epilepsy, yet the common variants contributing to epilepsy risk in the general population have not been evaluated in the context of TSC‐associated epilepsy. Such knowledge is important to help uncover the underlying pathogenesis of epilepsy in TSC which is not fully understood, and critical as uncontrolled epilepsy is a major problem in this population. To evaluate common genetic modifiers of epilepsy, our study pooled phenotypic and genotypic data from 369 individuals with TSC to evaluate known and novel epilepsy common variants. We did not find evidence of enhanced genetic penetrance for known epilepsy variants identified across the largest genome‐wide association studies of epilepsy in the general population, but identified support for novel common epilepsy variants in the context of TSC. Specifically, we have identified a novel signal in SLC7A1 that may be functionally involved in pathways relevant to TSC and epilepsy. Our study highlights the need for further evaluation of genetic modifiers in TSC to aid in further understanding of epilepsy in TSC and improve outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Abnormality of Early White Matter Development in Tuberous Sclerosis Complex and Autism Spectrum Disorder: Longitudinal Analysis of Diffusion Tensor Imaging Measures.
- Author
-
Srivastava, Siddharth, Yang, Fanghan, Prohl, Anna K., Davis, Peter E., Capal, Jamie K., Filip-Dhima, Rajna, Bebin, E. Martina, Krueger, Darcy A., Northrup, Hope, Wu, Joyce Y., Warfield, Simon K., Sahin, Mustafa, and Zhang, Bo
- Subjects
TUBEROUS sclerosis ,AUTISM spectrum disorders ,DIFFUSION tensor imaging ,WHITE matter (Nerve tissue) ,CALCULUS of tensors - Abstract
Background: Abnormalities in white matter development may influence development of autism spectrum disorder in tuberous sclerosis complex (TSC). Our goals for this study were as follows: (1) use data from a longitudinal neuroimaging study of tuberous sclerosis complex (TACERN) to develop optimized linear mixed effects models for analyzing longitudinal, repeated diffusion tensor imaging metrics (fractional anisotropy, mean diffusivity) pertaining to select white matter tracts, in relation to positive Autism Diagnostic Observation Schedule–Second Edition classification at 36 months, and (2) perform an exploratory analysis using optimized models applied to all white matter tracts from these data. Methods: Eligible participants (3-12 months) underwent brain magnetic resonance imaging (MRI) at repeated time points from ages 3 to 36 months. Positive Autism Diagnostic Observation Schedule–Second Edition classification at 36 months was used. Linear mixed effects models were fine-tuned separately for fractional anisotropy values (using fractional anisotropy corpus callosum as test outcome) and mean diffusivity values (using mean diffusivity right posterior limb internal capsule as test outcome). Fixed effects included participant age, within-participant longitudinal age, and autism spectrum disorder diagnosis. Results: Analysis included data from n = 78. After selecting separate optimal models for fractional anisotropy and mean diffusivity values, we applied these models to fractional anisotropy and mean diffusivity of all 27 white matter tracts. Fractional anisotropy corpus callosum was related to positive Autism Diagnostic Observation Schedule–Second Edition classification (coefficient = 0.0093, P =.0612), and mean diffusivity right inferior cerebellar peduncle was related to positive Autism Diagnostic Observation Schedule–Second Edition classification (coefficient = –0.00002071, P =.0445), though these findings were not statistically significant after multiple comparisons correction. Conclusion: These optimized linear mixed effects models possibly implicate corpus callosum and cerebellar pathology in development of autism spectrum disorder in tuberous sclerosis complex, but future studies are needed to replicate these findings and explore contributors of heterogeneity in these models. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. A comprehensive wireless neurological and cardiopulmonary monitoring platform for pediatrics
- Author
-
Wong, Jeremy N., primary, Walter, Jessica R., additional, Conrad, Erin C., additional, Seshadri, Dhruv R., additional, Lee, Jong Yoon, additional, Gonzalez, Husein, additional, Reuther, William, additional, Hong, Sue J., additional, Pini, Nicolò, additional, Marsillio, Lauren, additional, Moskalyk, Khrystyna, additional, Vicenteno, Mariana, additional, Padilla, Erik, additional, Gann, Olivia, additional, Chung, Ha Uk, additional, Ryu, Dennis, additional, du Plessis, Carlie, additional, Odendaal, Hein J., additional, Fifer, William P., additional, Wu, Joyce Y., additional, and Xu, Shuai, additional
- Published
- 2023
- Full Text
- View/download PDF
5. Epilepsy Severity Is Associated With Head Circumference and Growth Rate in Infants With Tuberous Sclerosis Complex
- Author
-
Levine, Alexis, primary, Davis, Peter, additional, Zhang, Bo, additional, Peters, Jurriaan, additional, Filip-Dhima, Rajna, additional, Warfield, Simon K., additional, Prohl, Anna, additional, Capal, Jamie, additional, Krueger, Darcy, additional, Bebin, E. Martina, additional, Northrup, Hope, additional, Wu, Joyce Y., additional, and Sahin, Mustafa, additional
- Published
- 2023
- Full Text
- View/download PDF
6. Tubers Affecting the Fusiform Face Area Are Associated with Autism Diagnosis.
- Author
-
Cohen, Alexander L., Kroeck, Mallory R., Wall, Juliana, McManus, Peter, Ovchinnikova, Arina, Sahin, Mustafa, Krueger, Darcy A., Bebin, E. Martina, Northrup, Hope, Wu, Joyce Y., Warfield, Simon K., Peters, Jurriaan M., and Fox, Michael D.
- Subjects
FUSIFORM gyrus ,TUBERS ,TUBEROUS sclerosis ,TEMPORAL lobe ,AUTISM spectrum disorders - Abstract
Objective: Tuberous sclerosis complex (TSC) is associated with focal brain "tubers" and a high incidence of autism spectrum disorder (ASD). The location of brain tubers associated with autism may provide insight into the neuroanatomical substrate of ASD symptoms. Methods: We delineated tuber locations for 115 TSC participants with ASD (n = 31) and without ASD (n = 84) from the Tuberous Sclerosis Complex Autism Center of Excellence Research Network. We tested for associations between ASD diagnosis and tuber burden within the whole brain, specific lobes, and at 8 regions of interest derived from the ASD neuroimaging literature, including the anterior cingulate, orbitofrontal and posterior parietal cortices, inferior frontal and fusiform gyri, superior temporal sulcus, amygdala, and supplemental motor area. Next, we performed an unbiased data‐driven voxelwise lesion symptom mapping (VLSM) analysis. Finally, we calculated the risk of ASD associated with positive findings from the above analyses. Results: There were no significant ASD‐related differences in tuber burden across the whole brain, within specific lobes, or within a priori regions derived from the ASD literature. However, using VLSM analysis, we found that tubers involving the right fusiform face area (FFA) were associated with a 3.7‐fold increased risk of developing ASD. Interpretation: Although TSC is a rare cause of ASD, there is a strong association between tuber involvement of the right FFA and ASD diagnosis. This highlights a potentially causative mechanism for developing autism in TSC that may guide research into ASD symptoms more generally. ANN NEUROL 2023;93:577–590 [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. Time to onset of cannabidiol treatment effect and resolution of adverse events in tuberous sclerosis complex: Post hoc analysis of randomized controlled phase 3 trial GWPCARE6
- Author
-
Wu, Joyce Y., primary, Cock, Hannah R., additional, Devinsky, Orrin, additional, Joshi, Charuta, additional, Miller, Ian, additional, Roberts, Colin M., additional, Sanchez‐Carpintero, Rocio, additional, Checketts, Daniel, additional, and Sahebkar, Farhad, additional
- Published
- 2022
- Full Text
- View/download PDF
8. Updated International Tuberous Sclerosis Complex Diagnostic Criteria and Surveillance and Management Recommendations
- Author
-
Northrup, Hope, primary, Aronow, Mary E., additional, Bebin, E. Martina, additional, Bissler, John, additional, Darling, Thomas N., additional, de Vries, Petrus J., additional, Frost, Michael D., additional, Fuchs, Zoë, additional, Gosnell, Elizabeth S., additional, Gupta, Nishant, additional, Jansen, Anna C., additional, Jóźwiak, Sergiusz, additional, Kingswood, J. Chris, additional, Knilans, Timothy K., additional, McCormack, Francis X., additional, Pounders, Ashley, additional, Roberds, Steven L., additional, Rodriguez-Buritica, David F., additional, Roth, Jonathan, additional, Sampson, Julian R., additional, Sparagana, Steven, additional, Thiele, Elizabeth Anne, additional, Weiner, Howard L., additional, Wheless, James W., additional, Towbin, Alexander J., additional, Krueger, Darcy A., additional, Annear, Nicholas M.P., additional, Bartels, Ute, additional, Berhouma, Moncef, additional, Bissler, John J., additional, Budde, Klemens, additional, Byars, Anna, additional, Chugani, Harry, additional, Cowen, Edward W., additional, Crino, Peter B., additional, Curatolo, Paolo, additional, de Vries, Petrus, additional, Dilling, Daniel F., additional, Dunn, David W., additional, Ekong, Rosmary, additional, Ess, Kevin C., additional, Franz, David N., additional, Frost, Michael, additional, Fuchs, Zoë D.B., additional, Gosnell, Elizabeth, additional, Guay-Woodford, Lisa, additional, Haddad, Luciana, additional, Halbert, Anne, additional, Hebert, Adelaide A., additional, Henske, Elizabeth P., additional, Holmes, Gregory L., additional, Hook, Dena, additional, Hulbert, John, additional, Jansen, Anna, additional, Johnson, Simon R., additional, King, Bryan, additional, Kingswood, J. Christopher, additional, Koenig, Mary Kay, additional, Korf, Bruce, additional, Kwiatkowski, David J., additional, Moss, Joel, additional, Mowat, David, additional, Mowrey, Kate, additional, Nabbout, Rima, additional, Nellist, Mark D., additional, Northrup, Hope, additional, O'Callaghan, Finbar, additional, Patel, Uday, additional, Roach, E. Steve, additional, Rodriguez-Buritica, David, additional, Romp, Robb, additional, Rozenberg, Micaela, additional, Ruoss, Stephen J., additional, Sahin, Mustafa, additional, Sampson, Julian, additional, Samuels, Joshua A., additional, Sauter, Matthias, additional, Smith, Catherine A., additional, Soltani, Keyomaurs, additional, Srivastava, Shoba, additional, Stuart, Clare, additional, Teng, Joyce M.C., additional, Thiele, Elizabeth A., additional, Trout, Andrew, additional, van Eeghen, Agnies, additional, Vanclooster, Stephanie, additional, Wang, Henry Z., additional, Wataya-Kaneda, Mari, additional, Witman, Patricia, additional, Wright, Tim, additional, Wu, Joyce Y., additional, and Young, Lisa, additional
- Published
- 2021
- Full Text
- View/download PDF
9. Epilepsy Is Heterogeneous in Early-Life Tuberous Sclerosis Complex
- Author
-
Ihnen, S. Katie Z., primary, Capal, Jamie K., additional, Horn, Paul S., additional, Griffith, Molly, additional, Sahin, Mustafa, additional, Bebin, E. Martina, additional, Wu, Joyce Y., additional, Northrup, Hope, additional, and Krueger, Darcy A., additional
- Published
- 2021
- Full Text
- View/download PDF
10. Limited utility of structural MRI to identify the epileptogenic zone in young children with tuberous sclerosis.
- Author
-
Nijman, Maaike, Yang, Edward, Jaimes, Camilo, Prohl, Anna K., Sahin, Mustafa, Krueger, Darcy A., Wu, Joyce Y., Northrup, Hope, Stone, Scellig S.D., Madsen, Joseph R., Fallah, Aria, Blount, Jeffrey P., Weiner, Howard L., Grayson, Leslie, Bebin, E. Martina, Porter, Brenda E., Warfield, Simon K., Prabhu, Sanjay P., and Peters, Jurriaan M.
- Abstract
Background and Purpose: The success of epilepsy surgery in children with tuberous sclerosis complex (TSC) hinges on identification of the epileptogenic zone (EZ). We studied structural MRI markers of epileptogenic lesions in young children with TSC. Methods: We included 26 children with TSC who underwent epilepsy surgery before the age of 3 years at five sites, with 12 months or more follow‐up. Two neuroradiologists, blinded to surgical outcome data, reviewed 10 candidate lesions on preoperative MRI for characteristics of the tuber (large affected area, calcification, cyst‐like properties) and of focal cortical dysplasia (FCD) features (cortical malformation, gray‐white matter junction blurring, transmantle sign). They selected lesions suspect for the EZ based on structural MRI, and reselected after unblinding to seizure onset location on electroencephalography (EEG). Results: None of the tuber characteristics and FCD features were distinctive for the EZ, indicated by resected lesions in seizure‐free children. With structural MRI alone, the EZ was identified out of 10 lesions in 31%, and with addition of EEG data, this increased to 48%. However, rates of identification of resected lesions in non‐seizure‐free children were similar. Across 251 lesions, interrater agreement was moderate for large size (κ =.60), and fair (κ =.24) for all other features. Conclusions: In young children with TSC, the utility of structural MRI features is limited in the identification of the epileptogenic tuber, but improves when combined with EEG data. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
11. Profile of Autism Spectrum Disorder in Tuberous Sclerosis Complex: Results from a Longitudinal, Prospective, Multisite Study.
- Author
-
Capal, Jamie K., Williams, Marian E., Pearson, Deborah A., Kissinger, Robin, Horn, Paul S., Murray, Donna, Currans, Kristn, Kent, Bridget, Bebin, Martina, Northrup, Hope, Wu, Joyce Y., Sahin, Mustafa, and Krueger, Darcy A.
- Subjects
AUTISM spectrum disorders ,TUBEROUS sclerosis ,MENTAL age ,DIAGNOSIS ,FACIAL expression - Abstract
Objective: Tuberous sclerosis complex (TSC) is highly associated with autism spectrum disorder (ASD). Objectives of the study were to characterize autistic features in young children with TSC. Methods: Participants included 138 children followed from ages 3 to 36 months with TSC from the Tuberous Sclerosis Complex Autism Center of Excellence Research Network (TACERN), a multicenter, prospective observational study aimed at understanding the underlying mechanisms of ASD in TSC. Developmental and autism‐specific assessments were administered, and a clinical diagnosis of ASD was determined for all participants at 36 months. Further analyses were performed on 117 participants with valid autism assessments based on nonverbal mental age greater than 15 months. Results: Prevalence of clinical diagnosis of ASD at 36 months was 25%. Nearly all autistic behaviors on the Autism Diagnostic Observation Schedule‐2 (ADOS‐2) and Autism Diagnostic Interview‐Revised (ADI‐R) were more prevalent in children diagnosed with ASD; however, autism‐specific behaviors were also observed in children without ASD. Overall quality of social overtures, facial expressions, and abnormal repetitive interests and behaviors were characteristics most likely to distinguish children with ASD from those without an ASD diagnosis. Participants meeting ADOS‐2 criteria but not a clinical ASD diagnosis exhibited intermediate developmental and ADOS‐2 scores compared to individuals with and without ASD. Interpretation: ASD is highly prevalent in TSC, and many additional individuals with TSC exhibit a broad range of subthreshold autistic behaviors. Our findings reveal a broader autism phenotype that can be identified in young children with TSC, which provides opportunity for early targeted treatments. ANN NEUROL 2021;90:874–886 [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.